• Explore /
  • Poster
  • / LCCC 1525: Combination immunotherapy with cyclophosphamide plus pembrolizumab in patients with advanced triple negative breast cancer (TNBC).

LCCC 1525: Combination immunotherapy with cyclophosphamide plus pembrolizumab in patients with advanced triple negative breast cancer (TNBC).

Abstract Poster

Authors

null

Benjamin Garrett Vincent

University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC

Benjamin Garrett Vincent , Dominic T. Moore , Susan G. Moore , Rebecca Davidson Kaltman , Shannon Puhalla , Vinay K. Gudena , Lisa A. Carey , Elizabeth Claire Dees , Hyman B. Muss , Katherine Elizabeth Reeder-Hayes , Trevor Augustus Jolly , Jonathan Stuart Serody , Carey K. Anders

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Triple-Negative

Clinical Trial Registration Number

NCT02768701

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS1125)

DOI

10.1200/JCO.2017.35.15_suppl.TPS1125

Abstract #

TPS1125

Poster Bd #

107b

Abstract Disclosures

Similar Posters

First Author: Scott S. Tykodi

First Author: Neelima Vidula

First Author: Sara M. Tolaney

First Author: Jae-Lyun Lee